Desulfotomaculum Details: NCBI 1562, gram-negative or unknown [genus]

| Desulfotomaculum| Desulfotomaculum Campbell and Postgate 1965

  1. Role in anaerobic environments: Desulfotomaculum species are adapted to anaerobic conditions and are known for their ability to metabolize a wide range of organic compounds, including simple sugars, organic acids, and complex polymers. They are particularly important in anaerobic environments such as wetlands and sediments, where they participate in the cycling of carbon, sulfur, and other elements.

  2. Ecological significance: While Desulfotomaculum species are primarily associated with environmental habitats, they may transiently colonize the human gastrointestinal tract under certain conditions. Their presence in the gut microbiota may contribute to the fermentation of dietary fibers and other complex carbohydrates, producing metabolites such as short-chain fatty acids (SCFAs) that can influence gut health and function.

  3. Potential probiotic properties: Some Desulfotomaculum species have been investigated for their potential probiotic properties, particularly in the context of animal health and agriculture. Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits on the host. While Desulfotomaculum species may not be as extensively studied as other probiotic bacteria, they have been evaluated for their ability to modulate gut microbiota composition, improve digestion, and enhance immune function in animals.

  4. Pathogenic potential: While Desulfotomaculum species are generally considered harmless or beneficial, under certain circumstances, they may have the potential to cause infections in humans, particularly in immunocompromised individuals or those with underlying health conditions. However, such cases are rare, and Desulfotomaculum species are not commonly associated with human diseases.

  5. Research gaps: Despite their ecological and potential probiotic significance, Desulfotomaculum species remain relatively understudied compared to other bacterial genera. Further research is needed to elucidate their metabolic capabilities, ecological roles, and potential contributions to human health and disease.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Desulfotomaculum

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 2.16 6 17780 0 11206 1659.9 110 4870.6 0 396 0 %ile 100 %ile
biomesight 50.71 0 30 10 90 0 986 97.2 40 453.6 0 80 0 %ile 90.6 %ile
thorne 100 6 79 0 67 31.9 27 18 13 45 0 %ile 100 %ile
thryve 81.41 0 122 28 176 0 477 119.3 77 182.3 7 199 12.1 %ile 90.4 %ile
ubiome 0.25 24 30 19 35 27 27 4.2 24 30 25 %ile 50 %ile

External Reference Ranges for Desulfotomaculum

Desulfotomaculum (NCBI 1562) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 0 27.12 0 0.0027
Statistic by Lab Source for Desulfotomaculum
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 54.06 %   0.008 %  0.04 % 1591.0 2943
BiomeSightRdp 34.375 %   0.014 %  0.018 % 11.0 32
bugspeak 100 %   0.011 %  % 1.0 1
CerbaLab 66.667 %   0.007 %  0.001 % 2.0 3
CosmosId 18.75 %   0.066 %  0.095 % 6.0 32
custom 34.426 %   0.935 %  0.906 % 21.0 61
es-xenogene 51.724 %   0.009 %  0.007 % 15.0 29
Medivere 100 %   0.015 %  0.012 % 7.0 7
SequentiaBiotech 25 %   0.03 %  0.022 % 9.0 36
Thorne 82.796 %   0.002 %  0.002 % 77.0 93
Thryve 83.177 %   0.012 %  0.017 % 1152.0 1385
uBiome 0.253 %   0.003 %  0 % 2.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc doxycycline (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc metronidazole (antibiotic)s[CFS] 2 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc minocycline (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high sugar diet 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) Cranberry 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) cranberry bean flour 2 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) walnuts 1 Studies recorded. The consensus is Increases👶, Click for details.
Miscellaneous, food additives, and other odd items gallate (food additive) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prebiotics and similar fructo-oligosaccharides (prebiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Sugar and similar saccharin 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.